TITLE

Fight Heartburn First with Lifestyle and Diet Changes

PUB. DATE
March 2007
SOURCE
Tufts University Health & Nutrition Letter;Mar2007, Vol. 25 Issue 1, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article looks at how a study published in the "Journal of the American Medical Association found that people over the age of 50 who took a type of popular heartburn drugs for a year or more had a significant increase in their risk for breaking a hip. The class of drugs cited in the study--proton pump inhibitors--includes brands such as Nexium and Prilosec. The article discusses the mechanics, symptoms, and treatments for gastroesophageal reflux disease.
ACCESSION #
24327546

 

Related Articles

  • Many taking twice daily proton pump inhibitors can step down.  // BMJ: British Medical Journal (International Edition);1/31/2004, Vol. 328 Issue 7434, p236 

    Investigates the question of whether or not reflux patients taking proton pump inhibitors (PPI) twice a day can reduce their dosage successfully. Synopsis of the problem; Study performed on reducing patient PPI levels; Conclusion that patients exhibiting no symptoms when taking high PPI doses...

  • GORD and the acid pocket.  // Australian Journal of Pharmacy;Sep2015, Vol. 96 Issue 1143, p19 

    The article offers information on gastro-oesophageal reflux disease (GORD), a complex disorder associated with various symptoms such as indigestion and heartburn that can be treated using proton pump inhibitors (PPIs).

  • Efficacy of Drugs Used in Gastro-Oesophageal Reflux: Network Meta-Analysis. Bolaños-Díaz, Rafael; Velarde-Criado, Héctor; Cóndor-Mori, Erik // Pharmacology & Pharmacy;Apr2013, Vol. 4 Issue 2, p201 

    Introduction: It is important to rank the clinical efficacy of different anti-reflux agents to promote their rational use. Objective: To combine the results of randomized clinical trials that have compared the incidence of symptoms related to gastro-oesophageal reflux (GER) with/without...

  • Proton Pump Inhibitors Therapy for Eosinophilic Esophagitis. Molina-Infante, Javier; Zamorano, Jose; Rivas, Maria D.; Fernandez-Bermejo, Miguel // Journal of Allergy & Therapy;Special2012, Vol. 3 Issue S, Special section p1 

    Proton pump inhibitors (PPIs) are the pharmacological cornerstone for acid-related peptic disorders, especially gastroesophageal reflux disease (GERD), on account of their powerful suppression of gastric acid secretion. GERD is the most common esophageal disease, with approximately 10-20% of...

  • Putting out the fire in the belly. Brophy Marcus, Mary // U.S. News & World Report;05/21/2001, Vol. 130 Issue 20, p71 

    Reports on a study published in the 'Journal of the American Medical Association' which found that surgery for gastrointestinal reflux is not as effective a treatment as drugs. Details of the study, which was conducted by researchers at the Veterans Affairs Medical Center in Dallas, Texas; The...

  • Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis. Hoogerwerf, W. A.; Pasricha, P. Jay // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p95 

    Comments on a study which compared lansoprazole and omeprazole in onset of heartburn relief in erosive esophagitis patients. Outcome measures; Effectiveness of lansoprazole and omeprazole in eliminating heartburn on patients with erosive esophagitis; Significance of proton-pump inhibitors to...

  • The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Boardman, Helen; Heeley, Gordon; Boardman, Helen F // International Journal of Clinical Pharmacy;Oct2015, Vol. 37 Issue 5, p709 

    Background: Heartburn and other symptoms of gastro-oesophageal reflux occur in ~30% of survey respondents in multiple countries worldwide. Heartburn and acid regurgitation are common complaints in the pharmacy, where patients frequently seek relief through medication and advice. The...

  • Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Riegler, Martin; Schoppman, Sebastian; Bonavina, Luigi; Ashton, David; Horbach, Thomas; Kemen, Matthias // Surgical Endoscopy;May2015, Vol. 29 Issue 5, p1123 

    Background: The techniques available for antireflux surgery have expanded with the introduction of the magnetic sphincter augmentation device (MSAD) for gastroesophageal reflux disease (GERD). Methods: A prospective, multicenter registry evaluated MSAD and laparoscopic fundoplication (LF) in...

  • Pantoprazole.  // AHFS Consumer Medication Information;Feb2018, p1 

    Pantoprazole is used to treat gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach). Pantoprazole is used to treat the symptoms of GERD, allow the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics